Emmanuelle Polge

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

Christoph Schmid, Myriam Labopin, Arnon Nagler et al. · Journal of Clinical Oncology · 2007 · 516 citations · Full text

Medicine, Hematology, Immunology +17

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

Christoph Schmid, Myriam Labopin, Arnon Nagler et al. · Blood · 2011 · 311 citations · Full text

Medicine, Hematology, Oncology +16

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

Fabio Ciceri, Myriam Labopin, Franco Aversa et al. · Blood · 2008 · 275 citations · Full text

Medicine, Hematology, Oncology +16

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

Martin Schmidt‐Hieber, Myriam Labopin, Dietrich W. Beelen et al. · Blood · 2013 · 225 citations

Medicine, Hematology, Oncology +14

Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis

Roni Shouval, Joshua Fein, Myriam Labopin et al. · The Lancet Haematology · 2019 · 222 citations

Medicine, Hematology, Immunology +17